Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants

Spontaneous mutants of susceptible clinical and laboratory isolates of Streptococcus pneumoniae exhibiting reduced susceptibility to evernimicin (SCH27899; MIC, 0.5 to 4.0 mg/liter) were selected on plates containing evernimicin. Four isolates that did not harbor mutations in rplP (which encodes rib...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Adrian, Peter V., Mendrick, Cara, Loebenberg, David, McNicholas, Paul, Shaw, Karen J., Klugman, Keith P., Hare, Roberta S., Black, Todd A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2000
Onderwerpen:
Mechanisms of Action: Physiological Effects
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC101610/
https://ncbi.nlm.nih.gov/pubmed/11036030
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items